155 related articles for article (PubMed ID: 36776923)
21. Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma.
Liu Z; Wan Y; Qiu Y; Qi X; Yang M; Huang J; Zhang Q
Int J Med Sci; 2020; 17(10):1393-1405. PubMed ID: 32624696
[No Abstract] [Full Text] [Related]
22. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma.
Huang G; Zhang J; Gong L; Huang Y; Liu D
BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809
[TBL] [Abstract][Full Text] [Related]
23. Protocadherin alpha 3 inhibits lung squamous cell carcinoma metastasis and epithelial-mesenchymal transition.
Tao Y; Fei L; Chang L; Yongyu L; Jianhui J; Yanan L; Yi R
Genes Genomics; 2022 Feb; 44(2):211-218. PubMed ID: 34086268
[TBL] [Abstract][Full Text] [Related]
24. MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells.
Zheng X; Zhang Y; Wu S; Jiang B; Liu Y
Mol Biotechnol; 2022 Jul; 64(7):832-840. PubMed ID: 35150405
[TBL] [Abstract][Full Text] [Related]
25. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
[TBL] [Abstract][Full Text] [Related]
26. The development and validation of a m6A-lncRNAs based prognostic model for overall survival in lung squamous cell carcinoma.
Huang H; Wu W; Lu Y; Pan X
J Thorac Dis; 2022 Oct; 14(10):4055-4072. PubMed ID: 36389308
[TBL] [Abstract][Full Text] [Related]
27. Systematic analysis of apoptosis-related genes in the prognosis of lung squamous cell carcinoma: a combined single-cell RNA sequencing study.
Zhu P; Yang W; Wang B; Zeng T; Hu Z; Zhang D; Yang Z; Wang K; Pu J
J Thorac Dis; 2023 Dec; 15(12):6946-6966. PubMed ID: 38249925
[TBL] [Abstract][Full Text] [Related]
28.
Zhang W; Zhang Q; Xie Z; Che L; Xia T; Cai X; Liu S
Front Genet; 2022; 13():839957. PubMed ID: 35719401
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis.
Zhang R; Zhang TT; Zhai GQ; Guo XY; Qin Y; Gan TQ; Zhang Y; Chen G; Mo WJ; Feng ZB
World J Surg Oncol; 2018 Jun; 16(1):109. PubMed ID: 29914539
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
Diao X; Guo C; Liu L; Wang G; Li S
Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
[TBL] [Abstract][Full Text] [Related]
31. MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.
Zhou Y; Yan J; Chen H; Zhou W; Xiao G; Zou H; Yang J
Appl Biochem Biotechnol; 2022 Jul; 194(7):3031-3043. PubMed ID: 35334070
[TBL] [Abstract][Full Text] [Related]
32. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Significance of Glycolysis-Related Genes in Lung Squamous Cell Carcinoma.
Kadasah SF
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256214
[TBL] [Abstract][Full Text] [Related]
34. Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma.
Li R; Liu X; Zhou XJ; Chen X; Li JP; Yin YH; Qu YQ
Front Oncol; 2020; 10():1588. PubMed ID: 33014809
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
Gao C; Zhuang J; Zhou C; Ma K; Zhao M; Liu C; Liu L; Li H; Feng F; Sun C
J Cell Physiol; 2019 May; 234(5):6519-6528. PubMed ID: 30246311
[TBL] [Abstract][Full Text] [Related]
36. A Novel Pyroptosis-Related Gene Signature for Early-Stage Lung Squamous Cell Carcinoma.
Li X; He J
Int J Gen Med; 2021; 14():6439-6453. PubMed ID: 34675612
[TBL] [Abstract][Full Text] [Related]
37. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
38. Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma.
Wang Q; Chen Y; Gao W; Feng H; Zhang B; Wang H; Lu H; Tan Y; Dong Y; Xu M
Front Oncol; 2022; 12():933925. PubMed ID: 35912252
[TBL] [Abstract][Full Text] [Related]
39. A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis.
Fan T; Lu Z; Liu Y; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J
Front Immunol; 2021; 12():665407. PubMed ID: 34177903
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage.
Du N; Zhang B; Zhang Y
Can Respir J; 2023; 2023():4533504. PubMed ID: 37547297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
